Empowered Funds LLC Has $1.17 Million Position in The Clorox Company $CLX

Empowered Funds LLC cut its holdings in The Clorox Company (NYSE:CLX) by 67.2% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 11,320 shares of the company’s stock after selling 23,182 shares during the quarter. Empowered Funds LLC’s holdings in Clorox were worth $1,173,000 as of its most recent SEC filing.

Other institutional investors have also recently bought and sold shares of the company. Haverford Trust Co lifted its stake in shares of Clorox by 2.8% in the 4th quarter. Haverford Trust Co now owns 3,070 shares of the company’s stock valued at $310,000 after purchasing an additional 84 shares during the period. Field & Main Bank grew its stake in shares of Clorox by 3.3% during the fourth quarter. Field & Main Bank now owns 3,100 shares of the company’s stock worth $313,000 after purchasing an additional 100 shares during the period. Golden State Wealth Management LLC grew its stake in shares of Clorox by 28.2% during the fourth quarter. Golden State Wealth Management LLC now owns 454 shares of the company’s stock worth $46,000 after purchasing an additional 100 shares during the period. Kestra Private Wealth Services LLC grew its stake in shares of Clorox by 1.8% during the first quarter. Kestra Private Wealth Services LLC now owns 5,957 shares of the company’s stock worth $617,000 after purchasing an additional 104 shares during the period. Finally, Johnson Financial Group Inc. increased its holdings in Clorox by 3.1% in the third quarter. Johnson Financial Group Inc. now owns 3,659 shares of the company’s stock valued at $451,000 after purchasing an additional 109 shares during the last quarter. Institutional investors and hedge funds own 78.53% of the company’s stock.

Clorox Stock Performance

Shares of Clorox stock opened at $105.24 on Friday. The company has a market capitalization of $12.73 billion, a PE ratio of 21.83, a PEG ratio of 3.13 and a beta of 0.54. The Clorox Company has a 12 month low of $84.70 and a 12 month high of $128.90. The company has a current ratio of 0.66, a quick ratio of 0.65 and a debt-to-equity ratio of 15.80. The stock’s fifty day simple moving average is $96.41 and its 200 day simple moving average is $103.46.

Clorox (NYSE:CLX) last posted its earnings results on Monday, August 3rd. The company reported $1.66 earnings per share for the quarter, topping the consensus estimate of $1.64 by $0.02. Clorox had a return on equity of 522.23% and a net margin of 8.74%.The firm had revenue of $1.95 billion for the quarter, compared to analyst estimates of $1.91 billion. During the same period in the previous year, the company posted $2.87 earnings per share. The company’s revenue for the quarter was down 2.0% on a year-over-year basis. Clorox has set its FY 2027 guidance at 5.700-6.000 EPS. On average, research analysts predict that The Clorox Company will post 5.82 EPS for the current year.

Clorox Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, August 28th. Stockholders of record on Wednesday, August 12th will be issued a dividend of $1.25 per share. This is a boost from Clorox’s previous quarterly dividend of $1.24. The ex-dividend date is Wednesday, August 12th. This represents a $5.00 annualized dividend and a dividend yield of 4.8%. Clorox’s dividend payout ratio (DPR) is presently 102.90%.

Analysts Set New Price Targets

CLX has been the topic of several analyst reports. BNP Paribas Exane cut their target price on Clorox from $97.00 to $95.00 and set a “neutral” rating on the stock in a research note on Monday, July 20th. Jefferies Financial Group lowered Clorox from a “buy” rating to a “hold” rating and decreased their target price for the stock from $125.00 to $98.00 in a research report on Tuesday, July 28th. Zacks Research cut Clorox from a “hold” rating to a “strong sell” rating in a research note on Tuesday, May 12th. The Goldman Sachs Group reiterated a “sell” rating and issued a $83.00 price target on shares of Clorox in a research report on Friday, May 1st. Finally, Deutsche Bank Aktiengesellschaft set a $98.00 price objective on shares of Clorox in a research note on Tuesday. Twelve investment analysts have rated the stock with a Hold rating and five have issued a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Reduce” and a consensus target price of $102.40.

Clorox Profile

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.